A new American health care coalition has been launched, focused on using AI to analyze eye data and support early detection of eye and systemic conditions.
The Alliance for Healthcare from the Eye (AHE) is a transversal initiative bringing together health systems, clinicians, non -profit organizations and decision -makers. The AI analysis of eye data such as retinal images and visual function tests is known as Oculomics.
The AHE plans to integrate the eye data collected by the approach in the coordinated care networks of primary care providers and primary care. A fundamental manuscript published in Jama ophthalmology Based, AHE members describe the main objective of the coalition: to move the health care of a reactive model to a proactive model by sharing eye data between the members of the AHE.
The manuscript describes how the ocular preselection fueled by AI can support “previous detection, extend access, reduce health care costs and help achieve a more efficient and accessible care model” thanks to the collaboration between the transversal sector and the existing clinical infrastructure.
Dr. Robert N Weinreb, professor and president of ophthalmology at the University of California in San Diego, and a founding member of the AHE, said: “The eye offers a non -invasive and high resolution window on the vascular, neurological and metabolic systems of the body.
“With advanced ophthalmic diagnoses, AI can help identify the first indicators of heart disease, renal dysfunction, neurodegeneration and other systemic diseases – before symptoms occur.”
The AHE was announced for the first time at the meeting of the association for Research in Vision and Ophthalmology (Arvo), which took place in Salt Lake City between May 4 and 8.
During the meeting, Lumithera published topline data for its processing of the Valeda light administration system to slow down the progression of macular degeneration linked to dry age (AMD). The results have shown that an earlier intervention And longer treatment has improved the effectiveness of the company’s photobiomodulation approach, which stimulates retinal cells to improve cellular function in dry DMLA patients and help slow the progress of the condition.
Roche Diagnostics launched its support behind a Comparable initiative of eye care and data sharing in the United Kingdom. Launched in March and led by the University of Liverpool, the digital bioresource of artificial eye cancer (Eye-Can-Aid) is a multimodal image database which aims to stimulate the early detection of cancers of rare eyes.
“A-Driven Eye Health Alliance Lalances in the United States” was originally created and published by Network of medical devicesA brand belonging to GlobalData.
